Stay updated on XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.

Latest updates to the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page
- CheckyesterdayChange DetectedThe study history adds a new Revision: v3.7.0 entry and removes the previous Revision: v3.6.6 entry, indicating an update to the history log rather than substantive changes to the trial data.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe history now shows a new Revision: v3.6.6 entry and removes the previous Revision: v3.6.5 from the log, representing a page version update in the study record history. This captures the latest UI/version change reflected in the study's revision history.SummaryDifference0.1%

- Check36 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.5 and removes the previous entry for v3.6.4, indicating a small software release update.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, replacing the previous v3.6.3 entry. This reflects an update to the record's revision status without changing the underlying trial information.SummaryDifference0.1%

- Check79 days agoChange DetectedThe revision history shows a new release tag, v3.6.3, replacing the previous v3.6.2. This indicates a software update applied to the page.SummaryDifference0.1%

- Check86 days agoChange DetectedThe record history shows a new revision tag, v3.6.2, being added and the previous tag, v3.6.0, being removed. This indicates an internal update to the page's versioning rather than changes to trial information.SummaryDifference0.1%

Stay in the know with updates to XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb20717 Safety & Efficacy in Rare Cancers Clinical Trial page.